首页> 外文OA文献 >Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice
【2h】

Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice

机译:卡马西平对妊娠小鼠胚胎眼发育的致畸作用

摘要

Background: Carbamazepine is an antiepileptic drug used widely for the treatment of epileptic seizures and neuropathic pain. Several malformations in humans, mainly neural tube defects, have been reported as a consequence of its use during pregnancy. The association between maternal use of carbamazepine and congenital eye malformations is not very well understood. Objective: The purpose of this study was to examine this association after intraperitoneal injection of carbamazepine during the period of organogenesis in mice. Methods: Balb/c timed-pregnant mice were divided into 4 experimental and control groups. Two experimental groups received daily intraperitoneal injections of 15mg/kg (group I) or 30mg/kg (group II) of carbamazepine on gestational days 6 to 15. Two control groups received normal saline or Tween 20 (polysorbate 20). Dams underwent Cesarean section on gestational day 18 and embryos were harvested. External examination for eye malformations, routine histological processing of malformed fetuses to study eye morphology, and skeletal staining were performed. Results: The mean weight and crown-rump of the fetuses in both experimental groups were significantly reduced compared with those of the control groups. Various malformations were detected such as brachygnathia, calvarial deformity, vertebral deformity, short tail, and brachydactyly. Premature opening of one or both eyes with mild to severe exophthalmos occurred in the 2 experimental groups. Deformed lens, retinal folds with undeveloped layers, and corneal folds with absence of surface epithelium were detected in both experimental groups. Conclusions: This study, to the best of our knowledge, showed for the first time that intraperitoneal administration of carbamazepine at clinically comparable doses during organogenesis can induce several eye malformations in mice. The implication of these results needs to be considered when carbamazepine is administered during human pregnancy. © 2010 Informa UK Ltd.
机译:背景:卡马西平是一种抗癫痫药,广泛用于治疗癫痫发作和神经性疼痛。由于在怀孕期间使用了多种畸形,主要是神经管畸形。孕产妇使用卡马西平与先天性眼畸形之间的关联不是很了解。目的:本研究的目的是研究小鼠器官发生期间腹膜内注射卡马西平后的这种相关性。方法:Balb / c定时妊娠小鼠分为4组实验组和对照组。两个实验组在妊娠第6至15天每天腹膜内注射卡马西平15mg / kg(I组)或30mg / kg(II组)。两个对照组接受生理盐水或Tween 20(聚山梨酯20)。在妊娠第18天对大坝进行剖腹产,并收获胚胎。进行了眼部畸形的外部检查,畸形胎儿的常规组织学处理以研究眼部形态以及骨骼染色。结果:与对照组相比,两个实验组的胎儿平均体重和冠臀均明显降低。检测到各种畸形,例如短颈,颅盖畸形,椎骨畸形,短尾巴和短颈畸形。在两个实验组中,一只眼或两只眼过早地睁开了轻度至重度眼球突出。在两个实验组中均检测到晶状体变形,具有未发育层的视网膜褶皱以及没有表面上皮的角膜褶皱。结论:据我们所知,这项研究首次表明,在器官发生过程中以临床上可比的剂量腹膜内给予卡马西平可诱发小鼠几种眼部畸形。在人怀孕期间服用卡马西平时,需要考虑这些结果的含义。 ©2010 Informa UK Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号